2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid

CAS: 594839-88-0

Ref. IN-DA00ECES

Información del producto

• Nombre: 2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid
• Sinónimos: [u'FX 1006A', u'FX-1006A', u'FX1006A', u'tafamidis', u'tafamidis meglumine', u'Vyndamax', u'Vyndaqel', u'TAFAMIDIS', u'594839-88-0', u'2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid', u'FX-1006', u'UNII-8FG9H9D31J', u'CHEBI:78538', u'8FG9H9D31J', u'2-(3,5-Dichlorophenyl)-6-benzoxazolecarboxylic Acid', u'C14H7Cl2NO3', u'2-(3,5-dichlorophenyl)benzoxazole-6-carboxylic acid', u'Tafamidis [USAN:INN]', u'tafamidisum', u'4his', u'Fx 1006', u'3MI', u'Tafamidis (USAN/INN)', u'SCHEMBL442508', u'GTPL8378', u'CHEMBL2103837', u'KS-00000TIG', u'DTXSID00208185', u'BCP29089', u'3096AH', u'BDBM50197883', u'MFCD16621109', u'ZINC43206271', u'AKOS017550076', u'CS-2821', u'DB11644', u'VS-0125', u'AK222900', u'AN-27718', u'HY-14852', u'DB-072645', u'FT-0674793', u'A14111', u'D09673', u'839D880', u'2-(3,5-Dichloro-phenyl)-benzooxazole-6-carboxylic acid', u'6-Benzoxazolecarboxylic acid, 2-(3,5-dichlorophenyl)-', u'Z2588039578', u'Discontinued until Pfizer approves it for our agreement""', u'FX-1006A|||2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid', u'Vyndaqel', u'Tafamidis meglumine', u'Vyndaqel (TN)', u'Tafamidis [USAN]', u'D04DFR', u'14H7Cl2NO3', u'Fx-1006A', u'Fx1006A', u'Fx 1006A', u'FX005', u'FX 005', u'ACN-036888', u'CID11001318', u'PF-06291826', u'2-(3,5-dichlorophenyl)benzooxazole-6-carboxylic Acid', u'137464-18-7']
• Marca: Indagoo

Propiedades químicas

• Peso molecular: 308.1163
• Fórmula: C₁₄H₇Cl₂NO₃
• Pureza: 98%
• Color/Forma: Solid
• InChI: InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)
• Clave InChI: TXEIIPDJKFWEEC-UHFFFAOYSA-N